Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $473.73 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $124.98 | 1 | $0 (2024) |
| UCB, Inc. | $122.29 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $97.81 | 1 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $48.52 | 2 | $0 (2021) |
| Allergan, Inc. | $46.57 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $33.56 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158.54 | 3 | ABBVIE INC. ($124.98) |
| 2021 | $24.69 | 1 | MERZ NORTH AMERICA, INC. ($24.69) |
| 2020 | $11.43 | 1 | Allergan, Inc. ($11.43) |
| 2019 | $23.83 | 1 | Merz North America, Inc. ($23.83) |
| 2017 | $255.24 | 5 | UCB, Inc. ($122.29) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Rare Disease | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Rare Disease | ||||||
| 11/23/2021 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Dermatology | ||||||
| 06/06/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/28/2019 | Merz North America, Inc. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $23.83 | General |
| Category: DERMATOLOGY | ||||||
| 09/11/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/07/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/15/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/30/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $122.29 | General |
| Category: Neurology | ||||||
| 01/24/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $97.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 261 | 268 | $155,790 | $30,759 |
| 2022 | 6 | 332 | 340 | $141,207 | $35,620 |
| 2021 | 4 | 385 | 392 | $173,989 | $47,253 |
| 2020 | 3 | 320 | 326 | $142,191 | $33,267 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 137 | 138 | $112,884 | $22,453 | 19.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 61 | 62 | $34,596 | $6,511 | 18.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 17 | 22 | $6,424 | $1,495 | 23.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 46 | 46 | $1,886 | $299.71 | 15.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 168 | 169 | $115,089 | $29,483 | 25.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 37 | 37 | $17,205 | $3,900 | 22.7% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 14 | 16 | $3,888 | $1,139 | 29.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 90 | 95 | $3,230 | $689.27 | 21.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 11 | 11 | $1,111 | $253.37 | 22.8% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 12 | 12 | $684.00 | $155.11 | 22.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 205 | 209 | $142,329 | $39,799 | 28.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 56 | 57 | $26,505 | $6,330 | 23.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 111 | 113 | $3,842 | $823.62 | 21.4% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 13 | 13 | $1,313 | $300.69 | 22.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 161 | 166 | $113,046 | $26,731 | 23.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 55 | 55 | $25,575 | $5,711 | 22.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 104 | 105 | $3,570 | $824.33 | 23.1% |
About Dr. Angela Cirilli, M.D
Dr. Angela Cirilli, M.D is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619187820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Cirilli, M.D has received a total of $473.73 in payments from pharmaceutical and medical device companies, with $158.54 received in 2024. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($473.73).
As a Medicare-enrolled provider, Cirilli has provided services to 1,298 Medicare beneficiaries, totaling 1,326 services with total Medicare billing of $146,899. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Manhasset, NY
- Active Since 05/23/2007
- Last Updated 07/29/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1619187820
Products in Payments
- DALVANCE (Drug) $158.55
- Vimpat (Drug) $122.29
- INVOKANA (Drug) $97.81
- ANDEXXA (Biological) $33.56
- Xeomin (Biological) $24.69
- XEOMIN (Biological) $23.83
- TEFLARO (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Jason Zemmel D'amore, Md, MD
Emergency Medicine — Payments: $4,719
Dr. Tadeusz Korszun, Md, MD
Emergency Medicine — Payments: $2,243
David Silver, Md, MD
Emergency Medicine — Payments: $1,153